Precision Biosciences

Developer of gene editing therapies to treat rare genetic diseases

placeDurham, North Carolina, United States calendar_todayFounded 2006 groups236 employees language precisionbiosciences.com

Registered entities

Innovation

29 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace steady. Cited 23 times.

YearFilings
20151
20161
20171
20186
20197
20208
20216
20223
202310
20247
20256
20262

Social engagement

Social engagement: 24.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

31 investors on record; lead investors include VenBio, ArrowMark Partners; 4 have since exited.

Investor typeCountShare
Venture capital1239%
Private equity310%
Accelerator & incubator13%
Bank & private debt26%
Other / undisclosed1342%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

10 Mar 2026 · Manager, Regulatory Affairs · Durham

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Event
Jefferies Global Healthcare Conference
10 Jun 2026
Event
CureDuchenne FUTURES National Conference
13 May 2026
Event
Peacement BioSciences virtual investor event on Duchenne Muscular Dystrophy (DMD)
Coming soon